Abbattista R, Feinberg N, Snodgrass I, Newman J, Dandekar A
Front Plant Sci. 2024; 15:1395543.
PMID: 38957599
PMC: 11217525.
DOI: 10.3389/fpls.2024.1395543.
Ferrasi A, Puttini R, Galvani A, Hamamoto Filho P, Delafiori J, Argente V
Int J Mol Sci. 2023; 24(10).
PMID: 37240159
PMC: 10218163.
DOI: 10.3390/ijms24108813.
Tucci P, Brown I, Bewick G, Pertwee R, Marini P
Int J Mol Sci. 2023; 24(4).
PMID: 36835033
PMC: 9962283.
DOI: 10.3390/ijms24043620.
Cherkasova V, Wang B, Gerasymchuk M, Fiselier A, Kovalchuk O, Kovalchuk I
Cancers (Basel). 2022; 14(20).
PMID: 36291926
PMC: 9600568.
DOI: 10.3390/cancers14205142.
Chistyakov D, Guryleva M, Stepanova E, Makarenkova L, Ptitsyna E, Goriainov S
Cancers (Basel). 2022; 14(8).
PMID: 35454947
PMC: 9032865.
DOI: 10.3390/cancers14082041.
The Interplay between Cancer Biology and the Endocannabinoid System-Significance for Cancer Risk, Prognosis and Response to Treatment.
Moreno E, Cavic M, Krivokuca A, Canela E
Cancers (Basel). 2020; 12(11).
PMID: 33167409
PMC: 7694406.
DOI: 10.3390/cancers12113275.
The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders.
Maia J, Fonseca B, Teixeira N, Correia-da-Silva G
Hum Reprod Update. 2020; 26(4):586-602.
PMID: 32347309
PMC: 7317288.
DOI: 10.1093/humupd/dmaa005.
Modulation of the Endocannabinoid System as a Potential Anticancer Strategy.
Ramer R, Schwarz R, Hinz B
Front Pharmacol. 2019; 10:430.
PMID: 31143113
PMC: 6520667.
DOI: 10.3389/fphar.2019.00430.
Oleoylethanolamide Supplementation Reduces Inflammation and Oxidative Stress in Obese People: A Clinical Trial.
Payahoo L, Khajebishak Y, Jafarabadi M, Ostadrahimi A
Adv Pharm Bull. 2018; 8(3):479-487.
PMID: 30276145
PMC: 6156479.
DOI: 10.15171/apb.2018.056.
Insights into the effects of the endocannabinoid system in cancer: a review.
Fraguas-Sanchez A, Martin-Sabroso C, Torres-Suarez A
Br J Pharmacol. 2018; 175(13):2566-2580.
PMID: 29663308
PMC: 6003657.
DOI: 10.1111/bph.14331.
Secretion, isotopic labeling and deglycosylation of N-acylethanolamine acid amidase for biophysical studies.
Pavlopoulos S, Pelekoudas D, Benchama O, Rawlins C, Agar J, West J
Protein Expr Purif. 2017; 145:108-117.
PMID: 29253688
PMC: 6022831.
DOI: 10.1016/j.pep.2017.12.005.
Effects of tumour necrosis factor α upon the metabolism of the endocannabinoid anandamide in prostate cancer cells.
Karlsson J, Gouveia-Figueira S, Alhouayek M, Fowler C
PLoS One. 2017; 12(9):e0185011.
PMID: 28910408
PMC: 5599064.
DOI: 10.1371/journal.pone.0185011.
Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6.
Schmitt J, Noble A, Otsuka M, Berry P, Maitland N, Rumsby M
Br J Cancer. 2014; 111(8):1646-56.
PMID: 25137020
PMC: 4200097.
DOI: 10.1038/bjc.2014.457.
The endocannabinoid system and sex steroid hormone-dependent cancers.
Ayakannu T, Taylor A, Marczylo T, Willets J, Konje J
Int J Endocrinol. 2013; 2013:259676.
PMID: 24369462
PMC: 3863507.
DOI: 10.1155/2013/259676.
Lipid analogues as potential drugs for the regulation of mitochondrial cell death.
Murray M, Dyari H, Allison S, Rawling T
Br J Pharmacol. 2013; 171(8):2051-66.
PMID: 24111728
PMC: 3976621.
DOI: 10.1111/bph.12417.
Cannabinoids, endocannabinoids, and cancer.
Hermanson D, Marnett L
Cancer Metastasis Rev. 2011; 30(3-4):599-612.
PMID: 22038019
PMC: 3366283.
DOI: 10.1007/s10555-011-9318-8.
Changes in the endocannabinoid system may give insight into new and effective treatments for cancer.
Alpini G, DeMorrow S
Vitam Horm. 2009; 81:469-85.
PMID: 19647123
PMC: 2791688.
DOI: 10.1016/S0083-6729(09)81018-2.
Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line.
Rimmerman N, Hughes H, Bradshaw H, Pazos M, Mackie K, Prieto A
Br J Pharmacol. 2007; 153(2):380-9.
PMID: 17965731
PMC: 2219527.
DOI: 10.1038/sj.bjp.0707561.
Mammalian cells stably overexpressing N-acylphosphatidylethanolamine-hydrolysing phospholipase D exhibit significantly decreased levels of N-acylphosphatidylethanolamines.
Okamoto Y, Morishita J, Wang J, Schmid P, Krebsbach R, Schmid H
Biochem J. 2005; 389(Pt 1):241-7.
PMID: 15760304
PMC: 1184557.
DOI: 10.1042/BJ20041790.
Levels of N-acylethanolamines in human tumors: in search of reliable data.
Maccarrone M, Fezza F, Finazzi-Agro A
Lipids. 2004; 39(2):193-4.
PMID: 15134148
DOI: 10.1007/s11745-004-1219-1.